Invea Therapeutics, Inc
INAI CIK: 0001906425
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type other
State of Incorporation DE
Business Address 2614 BOSTON POST ROAD, #33A, GUILFORD, CT, 06437
Mailing Address 2614 BOSTON POST ROAD, #33A, GUILFORD, CT, 06437
Phone 203-204-6363
Fiscal Year End 1231
EIN 873198325
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| S-1/A IPO registration amendment | January 27, 2026 | View on SEC |
| S-1/A IPO registration amendment | January 23, 2026 | View on SEC |
| S-1/A IPO registration amendment | January 7, 2026 | View on SEC |
| S-1 IPO registration statement | December 15, 2025 | View on SEC |
IPO Filings
S-1 December 15, 2025
- Biopharmaceutical company focused on discovering and developing breakthrough treatments for specific diseases.
- Goal is to bring innovative drugs to patients who currently don't have good options.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.